Korea advanced in global clinical trials, showing 3.41% market share last year

The number of clinical trials is decreasing, but the Korean clinical trial’s market share in the global market was actually increased by approx. 10% to 3.42%. There were changes in ranking as well because of the China’s significant jump.

According to the Korea National Enterprise for Clinical Trials’s(KoNECT) analysis result of National Institute of Health’s(NH) ClinicalTrials.gov, the world’s...